NEW YORK (GenomeWeb) – Horizon Discovery has formed a strategic partnership with Axol Bioscience to develop and commercialize genomically modified and differentiated induced pluripotent stem cells (iPSCs) for neuronal and cardiovascular research, the companies announced today. 

"This partnership builds on Axol’s strong position in the use of stem cell technology, and the combination of Horizon's gene editing expertise with Axol's experience in working with iPSCs will offer valuable new tools for researchers," Axol Chief Business Officer Sanj Kumar said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.